Drugs / amniotic epithelial cells
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02961712 Background | Jul 2016 → Oct 2017 | — | The Second Affiliated Hospital of Fujian Medical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | amniotic epithelial cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02961712 ↗ |
| Modality | Cell therapy | “cell therapy” NCT02961712 ↗ |
| Route | Intrathecal | “single intrathecal injection of amniotic epithelial cells” NCT02961712 ↗ |